Herman Philipe Nfombouot Njitoyap
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Herman Philipe Nfombouot Njitoyap has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Richard Njouom
Virology Unit Centre Pasteur du Cameroun Yaoundé Cameroon
2 shared publications - Wilfred Angie Abia
Department of Biochemistry, University of Yaounde 1, BP 812, Yaounde, Cameroon 2. Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, BT9 5DL, Northern Ireland, UK
2 shared publications Abdou Fatawou Modiyinji
Department of Virology Centre Pasteur of Cameroon Yaoundé Cameroon
1 shared publication- Abdourahmane Sow
Institut Pasteur de Dakar
1 shared publication - Aboubacar Soumah
Institut Pasteur de Bangui
1 shared publication - Adamou Lagare
Centre de Recherche Médicale et Sanitaire
1 shared publication
Latest Publications
- 16 August 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (8) , e71105
Identification and Molecular Characterization of 10 Novel Recombinant Variants of Hepatitis C Virus (HCV) in Cameroon Using Oxford Nanopore Sequencing and Phylogenomic Analysis
Hepatitis C virus (HCV) remains a major global public health concern due to the absence of an effective vaccine and its diversity, which complicate diagnosis, genotyping, and clinical management despite the widespread use of direct‐acting antivirals (DAAs). In regions where multiple HCV genotypes co‐circulate, inter‐genotypic recombination represents an additional challenge for accurate classification and molecular surveillance. In this study, we investigate the presence and characterize inter‐genotypic recombinant strains of HCV in Cameroon. Among 512 chronically infected patients initially genotyped by Sanger sequencing of Core and NS5B regions, 10 samples (1.9%) showed genotypic discordance, suggesting putative recombination. Whole‐genome sequencing using Oxford Nanopore technology, combined with phylogenomic and recombinant analysis, confirmed the recombinant nature of all 10 isolates. Most recombinant (7/10) shared a unique breakpoint in the NS2/NS3 region, primarily displaying a genotype 2/1 genomic profile, while one group had a breakpoint in the E2/p7 region (genotype 4/1 genomic profile). One isolate exhibited a more complex structure with two successive breakpoints (4/2 followed by 2/1). Genotypes 1 and 2 were the most frequently involved parental lineages. These findings demonstrate the ongoing circulation of diverse natural HCV recombinant forms in Cameroon and identify genomic regions that appear preferentially involved in recombination events. Our results highlight the limitations of genotypic approaches based on partial genomes and underscore the importance of comprehensive genomic characterization to improve HCV genotype classification, surveillance, and therapeutic strategies in Central Africa.
- 16 August 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (8) , e71105
Identification and Molecular Characterization of 10 Novel Recombinant Variants of Hepatitis C Virus (HCV) in Cameroon Using Oxford Nanopore Sequencing and Phylogenomic Analysis
Hepatitis C virus (HCV) remains a major global public health concern due to the absence of an effective vaccine and its diversity, which complicate diagnosis, genotyping, and clinical management despite the widespread use of direct‐acting antivirals (DAAs). In regions where multiple HCV genotypes co‐circulate, inter‐genotypic recombination represents an additional challenge for accurate classification and molecular surveillance. In this study, we investigate the presence and characterize inter‐genotypic recombinant strains of HCV in Cameroon. Among 512 chronically infected patients initially genotyped by Sanger sequencing of Core and NS5B regions, 10 samples (1.9%) showed genotypic discordance, suggesting putative recombination. Whole‐genome sequencing using Oxford Nanopore technology, combined with phylogenomic and recombinant analysis, confirmed the recombinant nature of all 10 isolates. Most recombinant (7/10) shared a unique breakpoint in the NS2/NS3 region, primarily displaying a genotype 2/1 genomic profile, while one group had a breakpoint in the E2/p7 region (genotype 4/1 genomic profile). One isolate exhibited a more complex structure with two successive breakpoints (4/2 followed by 2/1). Genotypes 1 and 2 were the most frequently involved parental lineages. These findings demonstrate the ongoing circulation of diverse natural HCV recombinant forms in Cameroon and identify genomic regions that appear preferentially involved in recombination events. Our results highlight the limitations of genotypic approaches based on partial genomes and underscore the importance of comprehensive genomic characterization to improve HCV genotype classification, surveillance, and therapeutic strategies in Central Africa.
- 24 January 2026
- Published by Springer Nature
- p. 81-100
ELISA-Based Protocols for Mycotoxin Detection Across Different Matrices in Africa
- 24 January 2026
- Published by Springer Nature
- p. 81-100
ELISA-Based Protocols for Mycotoxin Detection Across Different Matrices in Africa
- Open Access
- 5 January 2026
- Published by UK Scientific Publishing Limited in Environmental and Human Health
- Vol. 2 (1) , 1-17
Impact of Early‑Life Exposure to Environmental Neurotoxicants on Brain Development and Risk of Neurodevelopmental Disorders in Children
Environmental neurotoxicants pose significant risks to the developing brain, particularly during foetal and early postnatal periods when the blood-brain barrier is immature and highly permeable. Exposure during these critical windows of development can result in long-lasting structural and functional alterations to the nervous system, potentially leading to adverse neurodevelopmental and cognitive outcomes later in life. To synthesise current evidence on major environmental neurotoxicants, their mechanisms of action, neurodevelopmental effects, vulnerability factors, and implications for prevention and policy. A narrative review of published epidemiological, experimental, neuroimaging, and meta-analytic studies examining exposure to heavy metals, pesticides, industrial solvents, air pollutants, and endocrine-disrupting chemicals, with emphasis on developmental neurotoxicity and associated health outcomes. Environmental neurotoxicants disrupt neurodevelopment through oxidative stress, inflammation, excitotoxicity, apoptosis, epigenetic modifications, and neurotransmitter dysregulation. Prenatal and early-life exposures are associated with increased risks of autism spectrum disorder, attention-deficit/hyperactivity disorder, intellectual disabilities, behavioural disorders, reduced intelligence quotient (IQ), and structural brain abnormalities. Susceptibility is influenced by genetic factors, socioeconomic conditions, nutritional status, and combined exposures to multiple toxicants. Environmental neurotoxicants remain a major threat to child neurodevelopment, while current regulatory frameworks are insufficient to adequately protect vulnerable populations. Strengthened preventive measures, child-specific regulations, coordinated international testing, and equitable public health interventions are urgently needed to reduce exposure and safeguard brain health.
- 5 January 2026
- Published by UK Scientific Publishing Limited in Environmental and Human Health
- Vol. 2 (1) , 1-17
Open AccessImpact of Early‑Life Exposure to Environmental Neurotoxicants on Brain Development and Risk of Neurodevelopmental Disorders in Children
Environmental neurotoxicants pose significant risks to the developing brain, particularly during foetal and early postnatal periods when the blood-brain barrier is immature and highly permeable. Exposure during these critical windows of development can result in long-lasting structural and functional alterations to the nervous system, potentially leading to adverse neurodevelopmental and cognitive outcomes later in life. To synthesise current evidence on major environmental neurotoxicants, their mechanisms of action, neurodevelopmental effects, vulnerability factors, and implications for prevention and policy. A narrative review of published epidemiological, experimental, neuroimaging, and meta-analytic studies examining exposure to heavy metals, pesticides, industrial solvents, air pollutants, and endocrine-disrupting chemicals, with emphasis on developmental neurotoxicity and associated health outcomes. Environmental neurotoxicants disrupt neurodevelopment through oxidative stress, inflammation, excitotoxicity, apoptosis, epigenetic modifications, and neurotransmitter dysregulation. Prenatal and early-life exposures are associated with increased risks of autism spectrum disorder, attention-deficit/hyperactivity disorder, intellectual disabilities, behavioural disorders, reduced intelligence quotient (IQ), and structural brain abnormalities. Susceptibility is influenced by genetic factors, socioeconomic conditions, nutritional status, and combined exposures to multiple toxicants. Environmental neurotoxicants remain a major threat to child neurodevelopment, while current regulatory frameworks are insufficient to adequately protect vulnerable populations. Strengthened preventive measures, child-specific regulations, coordinated international testing, and equitable public health interventions are urgently needed to reduce exposure and safeguard brain health.
- Open Access
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1)
Development of Polyclonal Anti‐HBsAg IgY Antibodies and Comparative Evaluation of Glutaraldehyde Versus Periodate HRP Bioconjugation for Hepatitis B Diagnosis
Hepatitis B virus remains a major global health burden, particularly in sub‐Saharan Africa, where affordable, specific and locally producible diagnostic tools are urgently needed. Conventional mammalian antibody‐based assays can suffer from high background signals and interference in human sera. We developed a polyclonal chicken IgY reagent against the immunodominant “a” determinant of HBsAg, using consensus peptides to limit immune escape: two 24‐amino‐acid consensus peptides from the major hydrophilic region were synthesised and used to immunise laying hens. Antigen‐specific IgY was extracted from egg yolks by salting‐out precipitation, purified by peptide‐affinity chromatography and conjugated to horseradish peroxidase by glutaraldehyde cross‐linking and by sodium periodate oxidation. SDS‐PAGE under reducing and non‐reducing conditions confirmed the structural integrity of the purified IgY. Both chemistries yielded functional conjugates, but the periodate‐oxidised conjugate gave a significantly higher signal across dilutions (Wilcoxon test, p = 0.016). In an adapted commercial sandwich ELISA applied to 10 HBsAg‐positive and 10 HBsAg‐negative sera, the in‐house IgY–HRP conjugates produced optical density profiles that differed from the commercial biotinylated system (repeated‐measures ANOVA, p < 0.0001) while separating positive from negative sera completely. Receiver‐operating‐characteristic analysis gave an area under the curve of 1.000 for all three detection systems, and at the Youden‐derived cut‐offs (OD450 0.77 for the glutaraldehyde and 0.80 for the periodate conjugate) both in‐house reagents reached 100% sensitivity and 100% specificity (95% CI 72.2%–100% for each, n = 10 per group). This work establishes a low‐cost, locally producible IgY‐based platform for HBsAg detection, offering a scalable alternative for HBV screening in resource‐limited, high‐prevalence settings.
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1)
Open AccessDevelopment of Polyclonal Anti‐HBsAg IgY Antibodies and Comparative Evaluation of Glutaraldehyde Versus Periodate HRP Bioconjugation for Hepatitis B Diagnosis
Hepatitis B virus remains a major global health burden, particularly in sub‐Saharan Africa, where affordable, specific and locally producible diagnostic tools are urgently needed. Conventional mammalian antibody‐based assays can suffer from high background signals and interference in human sera. We developed a polyclonal chicken IgY reagent against the immunodominant “a” determinant of HBsAg, using consensus peptides to limit immune escape: two 24‐amino‐acid consensus peptides from the major hydrophilic region were synthesised and used to immunise laying hens. Antigen‐specific IgY was extracted from egg yolks by salting‐out precipitation, purified by peptide‐affinity chromatography and conjugated to horseradish peroxidase by glutaraldehyde cross‐linking and by sodium periodate oxidation. SDS‐PAGE under reducing and non‐reducing conditions confirmed the structural integrity of the purified IgY. Both chemistries yielded functional conjugates, but the periodate‐oxidised conjugate gave a significantly higher signal across dilutions (Wilcoxon test, p = 0.016). In an adapted commercial sandwich ELISA applied to 10 HBsAg‐positive and 10 HBsAg‐negative sera, the in‐house IgY–HRP conjugates produced optical density profiles that differed from the commercial biotinylated system (repeated‐measures ANOVA, p < 0.0001) while separating positive from negative sera completely. Receiver‐operating‐characteristic analysis gave an area under the curve of 1.000 for all three detection systems, and at the Youden‐derived cut‐offs (OD450 0.77 for the glutaraldehyde and 0.80 for the periodate conjugate) both in‐house reagents reached 100% sensitivity and 100% specificity (95% CI 72.2%–100% for each, n = 10 per group). This work establishes a low‐cost, locally producible IgY‐based platform for HBsAg detection, offering a scalable alternative for HBV screening in resource‐limited, high‐prevalence settings.
- Open Access
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 5
Strengthening Africa’s resilience to Mpox: Preparedness and response initiatives of the Pasteur network
The Journal of Public Health in Africa (JPHiA) is a peer-reviewed, academic journal that focuses on health issues in the African continent. The journal editors seek high quality original articles on public health related issues, reviews, comments and more. The aim of the journal is to move public health discourse from the background to the forefront. The success of Africa’s struggle against disease depends on public health approaches.
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 5
Open AccessStrengthening Africa’s resilience to Mpox: Preparedness and response initiatives of the Pasteur network
The Journal of Public Health in Africa (JPHiA) is a peer-reviewed, academic journal that focuses on health issues in the African continent. The journal editors seek high quality original articles on public health related issues, reviews, comments and more. The aim of the journal is to move public health discourse from the background to the forefront. The success of Africa’s struggle against disease depends on public health approaches.